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Mitochondrial dysfunction is implicated in a wide variety of
neurodegenerative disorders. The clinical features of mito-
chondrial disorders are extremely variable, but often a¡ect
heart and/or skeletal muscles and the central nervous system.
In humans, the 16 569-bp, maternally inherited mitochondrial
DNA (mtDNA) encodes 13 subunits of the electron transport
chain, 22 tRNAs, and 2 rRNAs. However, nuclear DNA
(nDNA) encodes the large majority of mitochondrial proteins.
Thus, normal function of the human mitochondrion involves
a highly complex interaction between the nuclear and mito-
chondrial genomes.
Mitochondrial diseases can therefore be a result of muta-
tions in mitochondrial or nuclear encoded genes. Disorders
caused by point mutations in the mtDNA include MELAS,
MERRF, NARP and LHON, while large-scale rearrange-
ments of mtDNA are the molecular features in Pearson’s or
Kearns^Sayre syndromes. Mitochondrial diseases caused by
nuclear defects include COX de¢ciency due to mutations in
the SURF-1 gene, Friedreich Ataxia, and spastic paraplegia.
Finally, there is a group of diseases where the defect is in a
nuclear gene, but a¡ecting mtDNA maintenance, thereby re-
sulting in mitochondrial dysfunction. This group of diseases is
associated with mtDNA depletion or multiple mtDNA dele-
tions. Mitochondrial diseases due to multiple mtDNA dele-
tions are genetically and clinically heterogeneous: autosomal
dominant and recessive forms and distinct clinical syndromes
have been described (http://www.ncbi.nlm.nih.gov/Omim).
The autosomal dominant form usually presents with adult-
onset progressive external ophthalmoplegia (adPEO) and
myopathy. Deafness and cataract are also common features
of this syndrome, while depression is a prominent feature in
one pedigree [1]. Tremor and levodopa responsive Parkinson-
ism, and a severe sensory ataxic axonal neuropathy have been
reported in some pedigrees (http://www.ncbi.nlm.nih.gov/
Omim). The multiple mtDNA deletions are most abundant
in muscle, but have also been detected at lower levels in other
autopsied post-mitotic tissues.
The Mendelian inheritance pattern implies the involvement
of nuclear genes in adPEO and adPEO has been mapped to
two di¡erent loci. Suomalainen et al. [2] assigned the ¢rst
disease locus to 10q23.3^24.3 in a large Finnish family. The
region was narrowed to 7 cM when a Pakistani family was
also shown to map to this region [3]. A second locus mapping
to 4q34^35 was reported [4] and recently, the heart/skeletal
muscle isoform of the adenine nucleotide translocator (ANT1)
gene was identi¢ed as the causative gene at this locus [5]. The
adPEO gene on chromosome 10 has not yet been identi¢ed. A
locus had previously been mapped in three Italian families to
3p14.1^21.2 but it has since been withdrawn [5].
We have identi¢ed another family with adPEO linked to
chromosome 10. Fourteen members were examined and 10
were found to be a¡ected with varying degrees of ptosis, ex-
ternal ophthalmoplegia, proximal weakness and bulbar weak-
ness. By history, another six family members are similarly
a¡ected. Muscle biopsies in two a¡ected patients, the proband
and her paternal cousin, showed patchy COX de¢ciency and
‘ragged-red’ ¢bres. In both patients, Southern blot analysis of
PvuII-digested (i.e. linearised) mtDNA from muscle, probed
with a mtDNA probe revealed multiple mtDNA deletions.
Respiratory chain enzyme assays showed a mild^moderate
reduction of activities of those subunits containing mtDNA-
encoded subunits, with normal or higher activity of the nu-
cleus-encoded complex II. This is similar to the previously
reported biochemical ¢ndings in adPEO [1].
Linkage analysis suggested linkage to the locus at 10q23.3^
24.3. Fine mapping of recombination sites in the family with a
further 10 markers (D10S541, D10S583, D10S198, D10S603,
D10S1266, D10S1268, D10S1738, D10S540, D10S530,
D10S566) de¢ned the critical region (approximately 13 cM)
to be between markers D10S1686 and D10S1738. Further de-
tails on the haplotype for this pedigree are located online
(http://www.elsevier.nl/PII/s0014579301026126). Suomalainen
et al. [2] de¢ned their critical region to a 20 cM region be-
tween markers D10S198 and D10S562, while Li et al. [3] de-
¢ned their region to a 10-cM region between markers
D10S1709 and D10S1795. These results suggest that the caus-
ative gene for adPEO is located in the approximately 3-cM
interval between D10S198 and D10S1738 where the three crit-
ical regions overlap (see Fig. 1A).
Primary candidate genes were selected from known genes
mapped to our critical region. They were chosen either be-
cause they had a known function in the mitochondria or that
they had mutant yeast homologues with a defective mitochon-
drial phenotype. We found no cDNA mutations or di¡erence
in expression levels, where investigated, in COX15, NADH:
ubiquinone oxidoreductase ASH1 subunit (NDFUB8) or
stearoyl-CoA desaturase (SCD). We therefore concluded
that combined with the expected function of these gene prod-
ucts neither COX15, NDUFB8, nor SCD are likely to be the
causative gene for adPEO. A fourth candidate gene, mito-
chondrial RNA splicing 4 (MRS4) gene, was originally de-
scribed in the yeast Saccharomyces cerevisiae, and its mutant
phenotype in yeast made it the most likely candidate gene for
adPEO [6]. Yeast MRS4 is 305 amino acid residues long and
belongs to a family of mitochondrial carrier proteins with
similar tripartite structures.
The gene structure and function of the human MRS4 ho-
mologue was unknown, but a search of EST databases indi-
cated that the protein is widely conserved and expressed in a
variety of human and other vertebrate tissues, including adult
human muscle and brain. By comparison of the cDNA se-
quence with a fully sequenced genomic BAC clone (NCBI
High-Throughput Genome Sequence, clone RP11-85A1), we
elucidated the gene structure. The human MRS4 gene covers
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approximately 10 kb, contains four exons and three introns
and predicts a protein of 364 amino acid residues in length. It
has an extended N-terminus region when compared with other
MRS4 protein sequences, the signi¢cance of this is not
known. This basic structure corroborates that reported in [7].
An unusual feature of MRS4 gene expression is the many
alternatively spliced mRNAs we found on analysing human,
mouse, bovine, pig, and rat cDNA clones in silico (Fig. 1B).
In fact, the majority of MRS4 cDNA clones that we have
sequenced, or for which cDNA sequence is available from
the I.M.A.G.E. consortium’s expressed sequence tag (EST)
database are splice variants. Many of these have long in-frame
reading frames and can potentially code for MRS4-like pro-
teins. Only one EST (AA878052, IMAGE 147912, which we
have called the consensus) appeared to be a full-length clone,
which we sequenced in its entirety on both strands (Fig. 1B).
The remainder did not contain the 5P end but incorporated
portions of intron 2, intron 3, or both. We ampli¢ed some of
these variants from patient and control muscle cDNA (data
not shown). No variants of intron 1 or alternative splicing in
this intron were noted. We sequenced the full 1.8-kb cDNA
from both patient and control muscle and no mutations were
found. Real-time PCR analysis of MRS4 RNA expression,
relative to citrate synthase RNA, in muscles also did not
show any signi¢cant di¡erence between patient and two nor-
mal quadriceps muscle samples.
Prediction of donor and acceptor sites in the consensus
MRS4 by analysis of the RP11-85A1 sequence (http://
www.hgsc.bcm.tmc.edu/SearchLauncher/), showed that only
the donor and acceptor sites used in intron 1 were recognised
as functional. The donor and acceptor sites used in intron 2
and intron 3 respectively were not recognised as suitable,
whereas their acceptor and donor counterparts were classed
as ideal. Indeed, there were other donor and acceptor sites in
all three introns, which were deemed more suitable than the
ones used. This could explain the many splice variants found.
Introns 2 and 3, where these splice variants are found, were
sequenced in both patient and control. We found no di¡er-
ences between patient and control. However, there was a dif-
ference between the published sequence of intron 2 in both
patient and control DNA that would introduce a new donor
site. The possible function and tissue-speci¢c expression of
these alternatively spliced mRNAs is not known. Sequencing
1.5 kb upstream of the putative start site incorporating the
promoter and its motifs did not show any mutations in the
patient.
MRS4 does not appear to be the causative adPEO gene.
However, it exhibits a very unusual expression pattern in the
many alternative spliced transcripts observed in several spe-
cies. The signi¢cance or function of these transcripts is not
known. The mechanism of how cells choose splice sites is not
well understood and functional splice sites do not always
match the consensus sequences well, while some that match
the consensus are not recognised by the splicing apparatus [8].
Mutations in the human thymidine phosphorylase gene
were shown to cause MNGIE [9] and mutations in ANT1
Fig. 1. A: Linkage map of adPEO region on 10q23.4-24.3. A map of the critical regions in the three studies and the overlapping interval. The
order of the markers is according to the Genome Database (http://www.gdb.org.au). B: Human and mouse MRS4 transcripts. All these tran-
scripts were found at the NCBI dbEST. Human EST’s: AA878052, AA654249, AA233896, H30227, AW361541. Mouse EST’S: AW21366,
W46092, AA517335. FFFF exonic sequence, lll intronic sequence.
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cause adPEO [5]. These examples show that mutations in
nuclear genes, encoding gene products without direct involve-
ment in mtDNA replication, can lead to accumulation of
mtDNA deletions. Our study has narrowed the candidate re-
gion for adPEO to a 3-cM gene-rich region at 10q23.3^24.3.
This will facilitate the identi¢cation of the causative gene for
chromosome 10 linked adPEO.
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